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Edited by David LambethAbstract Activation of the cysteine protease caspase-8 by the
death receptor Fas (CD95/APO-1) in B lymphoblastoid
SKW6.4 cells or Jurkat T cells is associated with GSH
depletion. Conversely, GSH depletion by the aldehyde acrolein
(3–30 lM) was associated with inhibition of Fas-induced
caspase-8 activation, although GSH depletion by buthionine
sulfoximine (BSO) did not aﬀect caspase-8 activation. In
contrast to BSO, acrolein caused a loss of caspase-8 cysteine
content in association with direct alkylation of caspase-8. Our
ﬁndings indicate that inhibition of caspase-8 by thiol-reactive
agents such as acrolein is not due to GSH depletion but caused
by direct protein thiol modiﬁcations.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The death receptor Fas (CD95/APO-1), a member of the
tumor necrosis factor superfamily, is involved in immune
system homeostasis and mediates cell apoptosis in response
to extrinsic stimuli by initial activation of the cysteine protease
caspase-8 (FLICE/MACHa1/Mch5). The mechanism of cas-
pase-8 activation is cell type-dependent [1], and is rapid in type
I cells in which it occurs primarily at the death-inducing signal-
ing complex (DISC), resulting in subsequent activation down-
stream caspases independent of mitochondrial activation.
Alternatively, Fas-mediated apoptosis in type II cells relies
more on mitochondrial pathways, and caspase-8 activation
occurs more slowly and is largely ampliﬁed by mitochondrial
perturbations.
Numerous previous studies have indicated that oxidative
events mediate apoptosis, either by activation of caspase cas-
cades through mitochondria-dependent pathways or by more
direct activation of death receptors such as Fas [2,3]. Accord-
ingly, a common feature of cell apoptosis is depletion of the
cellular antioxidant GSH [4]. Consistent with the suggested
role of GSH in preventing oxidative mechanisms of apoptosis
are observations that resistance against Fas-induced apoptosis
in certain cell types is associated with elevated cellular GSH*Corresponding author. Fax: +1 802 656 8892.
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doi:10.1016/j.febslet.2006.12.040levels, and that depletion of cellular GSH can eliminate the
resistant phenotype [5,6].
However, the relationship between cellular GSH status and
caspase-8 activation and apoptosis is controversial, and con-
ﬂicting reports exist in the literature. First, depletion of cellular
GSH during apoptosis is not due to its oxidation, but is caused
primarily by active GSH eﬄux, and inhibition of GSH eﬄux
can prevent apoptosis [4,7]. Furthermore, several recent stud-
ies have indicated that decreases in cellular GSH negatively
aﬀect caspase-8 activation [8,9], presumably related to the fact
that caspase-8 (as well as other caspases) contain redox-sensi-
tive critical cysteine residues and therefore require reducing
cellular conditions for optimal activity [9,10]. Accordingly, cell
exposure to thiol-reactive substances, such as the a,b-unsatu-
rated aldehydes acrolein or 4-hydroxynonenal, can inhibit cas-
pase activation and apoptosis in close association with
depletion of cellular GSH [11–13].
The present studies were designed to further clarify the rela-
tionship between cellular GSH status and Fas-mediated cas-
pase-8 activation, as well as the mechanisms by which the
a,b-unsaturated aldehyde acrolein, an important environmen-
tal pollutant and product of biological oxidation [13], aﬀects
caspase-8 activation. Because of suggested diﬀerences in
GSH regulation of Fas-mediated caspase-8 activation in diﬀer-
ent cell types [5], we investigated the consequences of changes
in cellular GSH status on Fas-mediated caspase-8 activation in
both SKW6.4 B lymphoblastoid (type I) cells and Jurkat T
(type II) cells. Our results indicate that GSH depletion follow-
ing Fas stimulation occurs primarily in type I cells, as a result
of caspase-8 activation. In addition, we report that inhibition
of caspase-8 activation by acrolein is not a direct result of
GSH depletion or cellular oxidant production, but is instead
associated with direct caspase-8 alkylation and modiﬁcation
of its cysteine residues.2. Materials and methods
2.1. Cell culture and treatments
The B lymphoblastoma cell line SKW6.4 was obtained from ATCC,
and propagated in RPMI 1640 medium (ATCC) supplemented with
10% fetal bovine serum. Jurkat T cells (ATCC) were maintained in
RPMI supplemented with 5% fetal bovine serum, 50 lM b-mercap-
toethanol, 1 mM pyruvate and 10 lg/ml folate [14]. For experiments,
cells were suspended at 2 · 106 cells/ml, treated with the appropriate
reagents, and harvested after various incubation periods for analysis
of caspase-8 activation. Treatments with acrolein (Sigma) were per-
formed in cell suspensions in HBSS, to avoid unwanted side reactions
of acrolein with culture media constituents, for up to 30 min (allowing
completion of acrolein reactions with cell components). For further
incubation and cell activation, HBSS was replaced regular RPMIblished by Elsevier B.V. All rights reserved.
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treatment and media exchanges. All reagents used were from Sigma
unless otherwise indicated.
2.2. Analysis of caspase-8 cleavage and activity
Following cell incubations, cells (2 · 106/ml) were lysed in 75 ll lysis
buﬀer (250 mM NaCl, 1.5 mM MgCl2, 50 mM HEPES, 1 mM EGTA,
1 mM PMSF, 2 mM Na3VO4, 10% glycerol, 1% Triton X-100, and
10 lg/ml of aprotinin and leupeptin), and full length and cleaved (acti-
vated) caspase-8 (p43/p41) were analyzed by 10% SDS–PAGE and
Western blotting using a mAb against caspase-8 (1C12; Cell Signaling).
Antibody binding was detected using HRP-conjugated anti-mouse IgG
(Cell Signaling) and visualized using enhanced chemiluminescence
(Pierce). Caspase-8 activity was also determined using a ﬂuorimetric
assay with IETD-AFC as substrate (R&D Systems), according to the
manufacturer’s instructions.
2.3. Analysis of cellular GSH
For analysis of cellular GSH, cell lysates were immediately deriva-
tized with monobromobimane (mBrB; Calbiochem), and GSH-mBrB
was analyzed by HPLC with ﬂuorescence detection [13]. Alternatively,
GSH and GSSG were analyzed simultaneously as dansyl derivatives by
HPLC and ﬂuorescence detection, as detailed previously [15].
2.4. Cellular peroxide production
Cells were pre-incubated with 2 0,7 0-dichloroﬂuorescein diacetate (H2
DCF-DA; 10 lM) for 30 min, and treated with acrolein (1–30 lM) for
an additional 30 min. In some cases, cells were pretreated with 100 lM
BSO, 24 h, prior to H2 DCF-DA. After washing with PBS, ﬂuores-
cence was analyzed using ﬂow cytometry. Results were based on a
minimum of 10000 counted cells, and staining with propidium iodide
was used to gate out dead cells.
2.5. Analysis of protein modiﬁcations using biotin labeling and avidin
chromatography
Protein cysteine residues were labeled by lysing treated or untreated
SKW6.4 or Jurkat T cells (20 · 106) in 500 ll lysis buﬀer containing
50 lM of the thiol-speciﬁc reagent EZ-link Maleimide-PEO2-Biotin
(Pierce), and 1 h incubation at RT. Alternatively, biotin labeling of
protein aldehyde adducts was performed by adding 22.5 ll biotin
hydrazide (Pierce; 100 mM in DMSO) to cell lysates (20 · 106 cells in
500 ll), and 2 h incubation at RT after which 450 ll NaBH4 (30 mM
in PBS) was added [16]. In both cases, unreacted biotinylating agent
was subsequently removed by gel ﬁltration on Sephadex G-25 columns
(PD-10; Amersham), and collected protein fractions (monitored by UV
absorbance at 280 nm) were applied to a column packed with 2 ml
Ultralink Immobilized Monomeric Avidin (Pierce) equilibrated with
buﬀer A (0.1 M Na2HPO4, 0.15 M NaCl; pH 7.2). After sample appli-
cation, columns were washed with Buﬀer A until the absorbance at
280 nm reached baseline, and biotinylated proteins were eluted with
4 mM D-biotin in Buﬀer A. To optimize elution of biotinylated pro-
teins, the pump was stopped for 5 min during this elution step. Col-
lected protein fractions were concentrated to about 100 ll using
Amicon Ultra4 10 kDa ﬁlters (Millipore), and proteins were then pre-
cipitated with 10% TCA and resuspended in Laemmli sample buﬀer for
analysis by SDS–PAGE and Western blotting using mAbs against cas-
pase-8 or caspase-3 (Cell Signaling).3. Results
3.1. Fas-mediated caspase-8 activation causes GSH depletion
We ﬁrst evaluated the kinetics of Fas/CD95-mediated cas-
pase-8 activation in relation to alterations in cellular GSH sta-
tus, in both SKW6.4 (type I) cells and Jurkat T (type II) cells
[1]. Consistent with earlier ﬁndings [1], Fas stimulation with
anti-Fas IgM CH11 (100 ng/ml; Upstate) caused rapid pro-
caspase-8 cleavage and caspase-8 activation in SKW6.4 cells,
while this was less pronounced and more delayed in Jurkat T
cells (Fig. 1A and B). Analysis of cellular GSH revealed that
Fas stimulation resulted in depletion of cellular GSH, as re-ported previously [4]. Consistent with these earlier ﬁndings,
this depletion was not associated with increased formation of
GSSG, but due to GSH eﬄux into the media (not shown).
Fas-mediated GSH eﬄux was more pronounced in SKW6.4
cells compared to Jurkat T cells (Fig. 1C). Fas-mediated cas-
pase-8 activation and GSH depletion appeared to be closely
associated, but caspase-8 activation was found to precede
GSH depletion. While caspase-8 activation was detectable
after 30 min (Fig. 1A and B), GSH levels did not decrease until
about 60 min after Fas stimulation (Fig. 1C). In addition, Fas-
mediated GSH depletion was signiﬁcantly reduced when cas-
pase-8 activation was inhibited using the caspase-8 inhibitor,
z-IETD-fmk (20 lM; Calbiochem; Fig. 1D). Hence, GSH
eﬄux following Fas stimulation appears to be a consequence
of caspase-8 activation, and occurs primarily in type I cells
in which caspase-8 activation is primarily associated with
DISC assembly [1,5].
3.2. Eﬀect of GSH depletion on caspase-8 activation
To further examine the relationship between GSH depletion
and caspase-8 activation, we used two independent approaches
to deplete cellular GSH. First, exposure of either SKW6.4 or
Jurkat cells to the a,b-unsaturated aldehyde acrolein, an
important environmental pollutant and an endogenous prod-
uct of several oxidative processes [17,18], causes a rapid (with-
in 10 min) decrease in cellular GSH at concentrations >1 lM
(Fig. 2A). This GSH depletion is largely due to direct or
GST-catalyzed GSH conjugation and elimination, and is not
associated with signiﬁcant oxidation to GSSG [13,19]. Second,
cells were pre-incubated with the GSH synthesis inhibitor
buthionine sulfoximine (BSO; 100 lM; Sigma), which causes
gradual and persistent depletion of cellular GSH, to
5.5 ± 2.9% and 10.4 ± 4.9% of initial levels (in SKW6.4 cells
and Jurkat T cells, respectively) after 24 h, comparable to the
extent of GSH depletion by 10–30 lM acrolein (Fig. 2A).
Analogous to previous results in neutrophils [13], exposure
of Jurkat T cells to acrolein biphasically aﬀected pro-cas-
pase-8 activation. Low concentrations (1–10 lM) enhanced
caspase-8 cleavage, whereas higher concentrations (>10 lM)
were markedly inhibitory (Fig. 2B). Similar treatment of
SKW6.4 cells with acrolein did not result in signiﬁcant
caspase-8 activation, but primarily showed inhibition of
caspase-8 cleavage at concentrations >10 lM. Given previous
reports indicating that acrolein can stimulate apoptosis by
mitochondrial pathways [20], the ability of acrolein to activate
caspase-8 would be expected to be more prominent in type II
cells (e.g. Jurkat T) than in type I cells (e.g. SKW6.4) [1,9].
Pretreatment of either SKW6.4 cells (Fig. 2C and D) or Jur-
kat T cells (not shown) with acrolein was found to dramati-
cally and dose-dependently inhibit Fas-mediated caspase-8
cleavage (Fig. 2C) and activity (Fig. 2D). Analogous to previ-
ous ﬁndings [13], this inhibitory eﬀect of acrolein on caspase-8
activation corresponded closely with the extent of GSH deple-
tion (Fig. 2A), suggesting a redox-dependent mechanism of
caspase-8 inactivation. However, in contrast to the eﬀects of
acrolein, comparable depletion of GSH by pre-incubation with
BSO did not result in signiﬁcant activation of caspase-8 nor
did it prevent Fas-mediated caspase-8 activation, in either
SKW6.4 cells (Fig. 2D) or Jurkat T cells (not shown). Western
blot analysis of caspase-8 cleavage suggested a slight activation
following pretreatment with BSO (Fig. 2C), which may be con-
sistent with previous observations of increased caspase-8 asso-
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Fig. 1. Fas-mediated caspase-8 activation and GSH depletion in type I and type II cells. (A) Time-dependent cleavage of caspase-8 upon Fas
stimulation with CH11 (100 ng/ml) in SKW6.4 (type I) or Jurkat T (typeII) cells. (B) Time-dependent increase in Fas-mediated caspase-8 activation
SKW6.4 (s) or Jurkat T (d) cells, analyzed using the ﬂuorogenic substrate IETD-AFC (mean ± S.D.; n = 3). (C) Analysis of cellular GSH following
Fas-stimulation of SKW6.4 (s) or Jurkat T (d) cells. GSH concentrations are expressed relative to initial concentrations (36 ± 6 and 56 ± 9 nmol/mg
protein in SKW6.4 and Jurkat T cells, respectively; mean ± S.D., n = 3). (D) Eﬀect of the caspase-8 inhibitor z-IETD-fmk (20 lM; 15 min pre-
incubation) on Fas-mediated GSH depletion in SKW6.4 cells (mean ± S.D., n = 3; *P < 0.05 compared to corresponding control; unpaired t-test).
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ever, no increase in basal or Fas-stimulated caspase-8 activity
was observed following BSO pre-incubation (Fig. 2D), perhaps
due to some oxidative inactivation of proteolytically activated
caspase-8 in BSO-treated cells. Although depletion of cellular
GSH by BSO pre-incubation did in itself not inhibit Fas-med-
iated caspase-8 activation, BSO pretreatment markedly poten-
tiated the inhibitory eﬀects of acrolein on Fas-mediated
caspase-8 activation in both SKW6.4 cells (Fig. 2C and D)
and Jurkat T cells (not shown).
Whereas the decrease in cellular GSH after Fas stimulation
was gradual and persistent (Fig. 1), GSH depletion in SKW6.4
cells by acrolein was rapid and was reversible over time, and
GSH levels were completely restored to initial levels after 4
hrs post-incubation (Fig. 3A), consistent with earlier observa-
tions [21]. Nearly identical results were obtained with Jurkat T
cells (data not shown). In contrast to the reversal of acrolein-
induced GSH depletion, the inhibitory eﬀect of acrolein
pretreatment on Fas-mediated caspase-8 activation was more
persistent, even after a 4 hrs recovery period between
SKW6.4 cell exposure to acrolein and Fas stimulation
(Fig. 3B). Thus, inhibition of caspase-8 activation by acrolein
does not appear to be directly related to GSH depletion, butmay be due to more irreversible modiﬁcations, perhaps within
caspase-8 itself.
3.3. Acrolein directly targets caspase-8 cysteine residues
To directly demonstrate modiﬁcations within caspase-8 un-
der these various experimental conditions, SKW6.4 cells or
Jurkat T cells were lysed in the presence of the cysteine-label-
ing agent biotin-PEO-maleimide, following cell exposure to
either acrolein or BSO. As expected, Western blot analysis of
biotinylated proteins obtained from untreated SKW6.4 cells
or Jurkat T cells revealed the presence of caspase-8
(Fig. 4A), indicating the presence of reduced cysteine residues
within caspase-8. Similar levels of biotinylated caspase-8 were
detected in cells that were treated with BSO for 24 h, indicating
that the cysteine content of caspase-8 was not signiﬁcantly
aﬀected even after >90% depletion of cellular GSH. In
contrast, almost no biotinylated caspase-8 was detected from
similarly derivatized SKW6.4 cells or Jurkat T cells after expo-
sure to 30 lM acrolein (Fig. 4A), indicating that the caspase-8
cysteine content was dramatically reduced. As shown in
Fig. 4B, the decrease in caspase-8 cysteine content by acrolein
was dose-dependent (Fig. 4B), and closely parallels cell deple-
tion of GSH (Fig. 2A). However, the fact that comparable
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Fig. 2. GSH depletion and regulation of caspase-8 activation by
acrolein and BSO. (A) Eﬀect of 30 min pre-treatment with indicated
concentrations of acrolein on GSH levels in SKW6.4 cells (open bars)
and Jurkat T cells (shaded bars). Alternatively, cells were pre-
incubated with 100 lM BSO for 24 h, prior to GSH analysis
(mean ± S.D., n = 3). (B) Dose-dependent eﬀect of acrolein on
caspase-8 cleavage in SKW6.4 or Jurkat T cells. Cells were treated
with acrolein for 30 min, and subsequently incubated in RPMI for an
additional 3.5 h before lysis. (C) Eﬀect of cell pre-treatment of with
indicated concentrations of acrolein (ACR; 30 min in HBSS) on CH11-
induced caspase-8 cleavage, measured after 4 h by Western blot
analysis, in untreated SKW6.4 cells (left panel) or cells that were
pretreated with 100 lM BSO (100 lM; 24 h; right panel). (D)
Measurement of CH-11-induced caspase-8 activity in SKW6.4 cells,
after cell exposure to acrolein (30 min in HBSS) or BSO using
treatment conditions as in panel (C). Mean data ± S.D. (n = 3) are
presented for control cells (no BSO; open bars) or cells that were pre-
incubated with BSO (100 lM, 24 h; shaded bars).
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Fig. 3. Reversibility of acrolein-induced GSH depletion and caspase-8
inhibition. (A) Time-dependent recovery of acrolein-induced GSH
depletion in SKW6.4 cells. Cells were treated with HBSS with (j) or
without (h) 10 lM acrolein for 30 min, and subsequently incubated in
RPMI medium for up to 4 h, before lysis and analysis of cellular GSH
(mean ± S.D., n = 3). (B) SKW6.4 cells were pre-incubated with
acrolein (30 min in HBSS) and stimulated either immediately with
CH11 (left panel) or after 4 h recovery in RPMI media prior to CH11
stimulation (right panel).
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cantly aﬀect caspase-8 cysteine status indicates that GSHdepletion was not responsible for caspase-8 modiﬁcation by
acrolein.
One of the main reactions of acrolein or related aldehydes
with proteins is via direct modiﬁcation of susceptible cysteine
residues to form a Michael-type thioether-linked aldehyde
adduct [22–24]. To demonstrate the presence protein-aldehyde
adducts within caspase-8 of acrolein-treated cells, we used bio-
tin hydrazide derivatization and avidin chromatography to
collect aldehyde-adducted proteins from cell lysates [16], and
analyzed these for the presence of caspase-8. Although little
caspase-8 was detectable in biotin hydrazide-derivatized pro-
teins from untreated cells, increasing amounts of caspase-8
were observed in lysates of cells that were exposed to 3–
30 lM acrolein (Fig. 4B). Moreover, the extent of biotin
hydrazide reactivity of caspase-8 was inversely related to
decreased cysteine content, as demonstrated with biotin-
PEO-maleimide labeling, strongly suggesting that acrolein
formed aldehyde conjugates within caspase-8 through alkyl-
ation of its cysteine residues. Because acrolein is likely to target
other cysteine-containing proteins in addition to caspase-8,
including other caspases, we also probed biotin-PEO-malei-
mide- and biotin hydrazide-labeled proteins for the presence
of caspase-3, after the various cell treatments. Indeed, as dem-
onstrated in Fig. 4B, acrolein also dose-dependently reduced
the cysteine content of caspase-3, and this was similarly asso-
ciated with corresponding increases of aldehyde adducts in this
protein, consistent with direct alkylation of caspase-3 cysteine
residues.
Acrolein and related unsaturated aldehydes are known to be
capable of enhancing cellular oxidant production [25,26], and
could therefore potentially inactivate caspase-8 by more indi-
rect oxidative mechanisms. To address this, we analyzed cellu-
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ment with acrolein and after pretreatment with BSO. As
shown in Fig. 4C, acrolein exposure caused dose-dependent in-
crease in cellular oxidant production (mean DCF ﬂuorescence
intensity increased from 3.2 ± 0.4 to 4.1 ± 0.7, 5.7 ± 0.8, and
9.6 ± 3.4, after treatment with 3, 10 and 30 lM acrolein,
respectively; means ± S.E., n = 3). Cell pre-incubation with
BSO also signiﬁcantly increased DCF ﬂuorescence, to an
extent comparable to that following exposure to 10 lM acro-
lein (mean DCF ﬂuorescence 6.9 ± 1.5 vs 5.7 ± 0.8; Fig. 4C).
Since, only acrolein treatment but not BSO pre-incubation re-
sulted in signiﬁcant loss of caspase-8 cysteine content (Fig. 4A
and B), production of cellular oxidants is unlikely to account
for the observed caspase-8 thiol loss and alkylation by acro-
lein.4. Discussion
Consistent with earlier reports [4,7], our results demonstrate
that Fas stimulation results in GSH depletion due to GSH
eﬄux. Fas-mediated GSH depletion was more prominent in
type I compared to type II cells, and was found to occur in
response to caspase-8 activation. Observations that inhibitors
of GSH eﬄux prevent some features of apoptosis [7,27] indi-
cate that GSH depletion is necessary for appropriate execution
of apoptosis. However, the cellular mechanisms by which acti-
vation of caspase-8 and/or downstream caspases promote
GSH eﬄux still remain to be clariﬁed. Although GSH deple-tion upon Fas stimulation is not responsible for caspase activa-
tion, a number of studies have claimed that Fas-mediated
caspase-8 activation and apoptosis may be intimately linked
with GSH status [5,6,8,9]. The present study partly dispels this
notion, and demonstrates that Fas-mediated caspase-8 activa-
tion does not critically depend on cellular GSH levels per se.
While cell exposure to the thiol-reactive aldehyde acrolein
markedly aﬀected caspase-8 activation in relation to GSH
depletion, similar depletion of GSH by inhibition of its synthe-
sis did not signiﬁcantly aﬀect caspase-8 activity. Indeed, the
inhibitory eﬀects of acrolein were uniquely associated with
direct modiﬁcation of cysteine residues within caspase-8, most
likely through their alkylation.
Our ﬁndings are in apparent contrast with several previous
studies that suggest that activation of caspase-8 is critically
dependent on cellular GSH status [8,9]. For example, Musal-
lam and co-workers [8] noted increased resistance against
Fas-induced apoptosis and caspase-8 after cell isolation and
culture in association with reduced overall GSH levels. How-
ever, it is possible that additional cellular changes during cell
culture, perhaps related to changes in GSH status, may have
contributed to the observed resistance against apoptosis.
Moreover, the relative modest changes in cellular GSH levels
or GSH/GSSG ratio observed by Musallam et al. would seem
insuﬃcient to dramatically aﬀect the cysteine status within cas-
pase-8. Indeed, we observed no signiﬁcant reduction in cas-
pase-8 cysteine content even after 90% depletion of GSH
with BS, perhaps because cellular redox status (GSH/GSSG
ratio) was not dramatically aﬀected.
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combination of BSO and alkylating agents prevented
Fas-mediated caspase-8 activation at DISC complexes. Our
current studies indicate that GSH depletion by BSO alone does
not block caspase-8 activation, and that inhibition of caspase-8
activation following exposure to the alkylating agent acrolein
was associated with direct alkylation of caspase-8 and modiﬁ-
cation of its cysteine residue(s). Hence, the ability of acrolein
to inhibit caspase-8 activation appears to rely on direct protein
modiﬁcations, rather than indirect cellular oxidant formation
or other changes following depletion of GSH. Based on our
ﬁndings, the inhibitory eﬀects observed by Hentze et al. were
most likely caused by direct modiﬁcation of caspase-8 by the
alkylating agents used. Alternatively, extensive and prolonged
GSH depletion after combined exposure to BSO and thiol-
reactive alkylating agents could have caused indirect oxidation
of critical cysteines within caspase-8, but this was unfortu-
nately not addressed by Hentze et al. The observed reversal
of caspase-8 inhibition by subsequent addition of GSH [9] does
not rule out direct thiol alkylation reactions which can also be
reversible in the presence of thiols [22]. In this regard, thio-
ether adducts with acrolein are known to be relatively stable
[22], consistent with the lack of reversal of caspase-8 inactiva-
tion even after 4 h recovery period following acrolein treat-
ment (Fig. 3).
Although our studies speciﬁcally address inhibitory eﬀects of
one thiol alkylating agent, acrolein, they may have more gen-
eral implications for mechanisms by which caspases or other
redox-sensitive signaling pathways are aﬀected by cellular or
environmental oxidants or thiol-reactive agents. Our ﬁndings
suggest that such regulation most likely occurs by direct oxida-
tion/alkylation of susceptible protein cysteine residues, rather
than by indirect oxidative modiﬁcations in response to GSH
depletion. Indeed, GSH depletion by BSO was found to be
insuﬃcient in regulating caspase activation, in the absence of
active oxidant production or generation of alkylating agents.
Although this concept has been generally accepted in the con-
text of redox signaling by biological oxidants produced by, e.g.
Nox enzymes, it can be extended to biological signaling path-
ways initiated by reactive aldehydes (such as acrolein or
hydroxynonenal) that can be generated in speciﬁc cellular
regions as a result of localized oxidative events. In contrast
to cellular reducing systems (e.g. glutaredoxins) that serve to
reverse protein cysteine oxidation or thiolation, no speciﬁc
enzymatic systems capable of reversing alkylation of reactive
protein cysteine residues by acrolein or related electrophiles
are known to exist. Thus, thiol modiﬁcations by acrolein or
related aldehydes may be reversed primarily by protein turn-
over, or to slow dissociation of these adduct in the presence
of GSH or other thiols [22]. In addition, cell systems appear
to rely largely on various detoxiﬁcation systems that reduce
unsaturated aldehydes such as acrolein [19,28,29], to mini-
mize their ability to alkylate redox-sensitive protein targets
such as caspase-8. Accordingly, depletion of cellular GSH
should diminish GSH-dependent detoxiciﬁcation of acrolein
[19], and thereby allow acrolein to target and inactivate suscep-
tible proteins such as caspase-8, as was observed in our studies.Acknowledgements: The authors thank Scott Tighe and Umadevi
Wesley for their assistance with ﬂow cytometry. This work was sup-
ported by NIH Grants HL68865 and NH074295.References
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